BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Med’s Industry

Japan Grants Orphan Drug Designation to JR-446 for Sanfilippo Syndrome Type B

MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Co., Ltd. announced that the Ministry of Health, Labour and Welfare of Japa...

October 01, 2025 | News

Olympus Launches OLYSENSE™ AI Endoscopy Portfolio in US and Europe

Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today ann...

October 01, 2025 | News

Pier 88 Health and Theranica Secure NMPA Approval for Nerivio® REN Wearable in China

Pier 88 Health, a digital health company dedicated to reshaping chronic pain management and bringing breakthrough global medical innovations to Greate...

September 30, 2025 | News

Lupin To Acquire VISUfarma To Expand European Specialty Ophthalmology Presence

Global pharma major Lupin Limited announced its wholly owned subsidiary, Nanomi B.V. ('Nanomi'), has signed a definitive agreement for the acqui...

September 30, 2025 | News

Lumonus Partners With Smarter Radiation Oncology® to Expand AI-Driven, Standardised Cancer Care Worldwide

Lumonus, a healthcare technology company transforming cancer care with its AI-powered platform, announced a multi-year agreement with Smarter Radiation Onc...

September 30, 2025 | News

AbbVie Submits FDA Application for Tavapadon After Positive Phase 3 TEMPO Results in Parkinson’s Disease

Submission supported by data from the Phase 3 TEMPO program that demonstrated symptomatic improvement across the Parkinson's disease spectrum Positive r...

September 29, 2025 | News

COREE Identifies First-Ever Microbiome Biomarkers for Diabetes and Obesity Patients

COREE announced on September 15 that it had, for the first time in the world, identified microbiome biomarkers specific to diabetes and obesity p...

September 29, 2025 | News

Leo Cancer Care and Sumitomo Heavy Industries Partner to Launch Upright Proton Therapy Solution

Leo Cancer Care, a leader in innovative cancer care solutions, and Sumitomo Heavy Industries, a global pioneer in medical technology, have announced a stra...

September 29, 2025 | News

Noul Secures FDA Registration for miLab™ CER Cervical Cancer Diagnostic, Paving Way for US Market Entry

Noul Co., Ltd. (CEO: David Lim), a medical AI company specializing in blood and cancer diagnostics, announced that FDA registration has been completed...

September 26, 2025 | News

Lunit and CellCarta Form Global Partnership to Advance AI-Powered Pathology in Clinical Trials

Lunit , a leading provider of AI for cancer diagnostics and biomarkers for oncology therapeutics, announced a strategic partnership with CellCarta, a globa...

September 25, 2025 | News

QIAGEN and APAGE Convene Asia-Pacific Experts to Set New Consensus on GI Infection Diagnostics

QIAGEN, in collaboration with APAGE, organized a regional meeting in Malaysia to share insights in GI diagnostics Over 10 leading key opinio...

September 24, 2025 | News

Lunit and Agilent Forge Collaboration to Develop AI-Powered Companion Diagnostics

Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabili...

September 23, 2025 | News

China’s NMPA Approves Innovent’s Mazdutide, the World’s First Dual GCG/GLP-1 Receptor Agonist for Type 2 Diabetes

Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatm...

September 22, 2025 | News

Roche Wins First CLIA ‘Moderate Complexity’ Designation for Mass Spectrometry Vitamin D Test

First mass spectrometry-based test system for total 25-Hydroxyvitamin D to receive CLIA 'Moderate Complexity' designation in the U.S....

September 19, 2025 | News

Stay Connected